HIMS vs LLY · P/E 74, rev $1.36B vs P/E 39, rev $22.97B
Hims Hers Health Inc (HIMS) versus Eli Lilly and Company (LLY) — a side-by-side from cached financials, not a winner call.
Hims Hers Health Inc (HIMS) is a household & personal products company listed on US.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David Ricks.
Latest reported HIMS revenue for 2026-06-30 was $1.36B. Net income was -$178.4M. HIMS currently screens at market cap $11.04B and trailing P/E 73.9.
Latest reported LLY revenue for 2026-06-30 was $22.97B. Net income was $7.09B. Revenue was up 16.0% from 2026-03-31 to 2026-06-30. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
HIMS currently screens at market cap $11.04B and trailing P/E 73.9. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Not investment advice. Open the HIMS and LLY stock pages for the full models.
Not investment advice.